Share / Print

Aswath Damodaran

Aswath Damodaran

Joined Stern 1986

Leonard N. Stern School of Business
Kaufman Management Center
44 West Fourth Street, 9-94
New York, NY 10012

Personal website
Follow on Twitter


Aswath Damodaran holds the Kerschner Family Chair in Finance Education and is Professor of Finance at New York University Stern School of Business. Before coming to Stern, he also lectured in Finance at the University of California, Berkeley.

Professor Damodaran received a B.A. in Accounting from Madras University and a M.S. in Management from the Indian Institute of Management. He earned an M.B.A. (1981) and then Ph.D. (1985), both in Finance, from the University of California, Los Angeles.

Professor Damodaran's contributions to the field of Finance have been recognized many times over. He has been the recipient of Giblin, Glucksman, and Heyman Fellowships, a David Margolis Teaching Excellence Fellowship, and the Richard L. Rosenthal Award for Innovation in Investment Management and Corporate Finance.

His skill and enthusiasm in the classroom garnered him the Schools of Business Excellence in Teaching Award in 1988, and the Distinguished Teaching award from NYU in 1990. His student accolades are no less impressive: he has been voted "Professor of the Year" by the graduating M.B.A. class five times during his career at NYU.

In addition to myriad publications in academic journals, Professor Damodaran is the author of several highly-regarded and widely-used academic texts on Valuation, Corporate Finance, and Investment Management.

Professor Damodaran currently teaches Corporate Finance and Equity Instruments & Markets. His research interests include Information and Prices, Real Estate, and Valuation.

Research Interests

  • Information and Prices
  • Real Estate
  • Valuation

Courses Taught

  • Corporate Finance
  • Equity Instruments & Markets

Academic Background

Ph.D., Finance, 1985

M.B.A., Finance, 1981

M.S., Management, 1979
Indian Institute of Management

B.Com., Accounting, 1977
Madras University

Related News & Research

Key takeaways from Professor Aswath Damodaran's recent analysis of the market impacts of COVID-19 are referenced

Professor Aswath Damodaran's valuation model is referenced in a story about Tesla's rising share price

Professor Aswath Damodaran's recent blog post on the valuation of Tesla is mentioned

Professor Aswath Damodaran shares his thoughts on the value of Tesla and asserts that Elon Musk is the company's biggest danger to future growth

Professor Aswath Damodaran's comments on the market effects of IPO lockups are referenced

"Professor Aswath Damodaran's recent valuation analysis on Aramco is cited "

Professor Aswath Damodaran discusses the steep decline in WeWork's valuation and its impact on other companies in SoftBank's portfolio

Professor Aswath Damodaran weighs in on Aramco's valuation ahead of its IPO

Professor Aswath Damodaran offers insight into the recent stock performances of Uber and Beyond Meat in response to the expiration of their IPO lockups and initial earnings reports

Professor Aswath Damodaran shares his thoughts on how the 2019 IPO market will affect companies contemplating a move to go public

Professor Aswath Damodaran's thoughts on the connection between zero brokerage commissions and investor cost savings are featured

In a live interview, Professor Aswath Damodaran comments on the IPO market and the divergence between private and public pricing

Professor Aswath Damodaran comments on the state of Netflix as Apple and Disney prepare to launch their streaming platforms

Professor Aswath Damodaran comments on the pros and cons of reducing brokerage commissions to zero

Research from Professor Aswath Damodaran explaining the difference between voting and non-voting shares is referenced

Professor Aswath Damodaran is interviewed for an article on Netflix's growth

Professor Aswath Damodaran's blog post on WeWork's valuation is featured

Professor Aswath Damodaran's presentation on valuation at an RBSA Advisors event in Mumbai is featured

Professor Aswath Damodaran's research on pharmaceutical companies' profit margins is cited

Why Investors Should Be Wary of Stock-Based Compensation

Areas of Expertise


  • Earnings Management
  • Shareholder Issues/Activism
  • Valuation


  • Berkshire Hathaway


  • Asset Management
  • Corporate Finance
  • Corporate Governance
  • Portfolio Management
  • Valuation


  • Housing/Real Estate


  • Restructuring & Layoffs